Results 151 to 160 of about 30,832 (224)

Crowded Decisions: How Environmental Density Shapes Mobile Investment Behavior

Psychology &Marketing, EarlyView.
ABSTRACT Neo‐brokers have democratized access to the stock market, primarily through mobile platforms, attracting novice retail investors. However, research on the influence of environmental factors on mobile investment behavior is scarce. In this paper, we investigate how the immediate environment of potential investors influences their decisions and ...
Pauline Engel, Chen Pundak, Martin Spann, Peter Pal Zubcsek   +3 more
wiley   +1 more source

A Colloidal Gold Immunochromatographic Strip Based on a Conserved Epitope Peptide for Rapid Detection of Antibodies Against Avian Infectious Bronchitis Virus. [PDF]

Microorganisms
Liu L, Zhao K, Zhao CR, Zhang TN, Li Y, Wu Q, Wang Q, Yang CR, Zhao WQ, Chen QY, Wei T, Huang T, Huang J, Mo M.   +13 more
europepmc   +1 more source

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta‐Analysis

Movement Disorders, EarlyView.
Abstract Background Variants in GBA1 are important genetic risk factors for synucleinopathies, including Parkinson's disease (PD). Although several GBA1 variants are established risk or severity modifiers, the role of the p.E427K variant remains unclear.
Leah V. Chifamba, Sitki Cem Parlar, Emma N. Somerville, Lang Liu, Eric Yu, Farnaz Asayesh, Jamil Ahmad, Meron Teferra, Jennifer A. Ruskey, Cheryl Waters, Oury Monchi, Yves Dauvilliers, Nicolas Dupré, Alla Timofeeva, Anton Emelyanov, Sofya Pchelina, Irina Miliukhina, Lior Greenbaum, Sharon Hassin‐Baer, Orly Goldstein, Mandy Radefeldt, Peter Bauer, Christian Beetz, Allison A. Dilliott, James C. Beck, Konstantin Senkevich, ROPAD Study Group, The Parkinson's Foundation PD GENEration Study, Christine Klein, Roy N. Alcalay, Ziv Gan‐Or   +30 more
wiley   +1 more source

Antibodies in tuberculosis: functional capacity as key determinant. [PDF]

Infect Immun
van Meijgaarden KE, Grace PS, Freund NT, Achkar JM, Lindenstrøm T, Tan J, Chan J, King CG, Ottenhoff THM, Joosten SA, CTVD B cell group.   +10 more
europepmc   +1 more source

The Effect of LRRK2 and GBA1 Mutations on Survival in Early‐ and Late‐Onset Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Mutations in the glucocerebrosidase 1 (GBA1) and leucine‐rich repeat kinase 2 (LRRK2) genes are associated with Parkinson's disease (PD) phenotype. Objective To asses the contribution of genetic status to long‐term survival of patients with PD.
Raz Rubin, Roy N. Alcalay, Nurit Omer, Orly Goldstein, Mali Gana Weisz, Anat Mirelman, Avner Thaler   +6 more
wiley   +1 more source

Identification of Conserved Cross-Reactive B-Cell Epitopes in CPV1 and CPV2 L1 Proteins with Vaccine Potential. [PDF]

Vaccines (Basel)
Wang Y, Chen Y, Wang K, Yuan Y, Sun H, Yuan Y, Wang J, Yang Z, Yang Y, Wang N, Duan D, Wang A.   +11 more
europepmc   +1 more source

Timing of Deep Brain Stimulation and Cognitive Trajectories in GBA1‐Associated Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Background Individuals with Parkinson's disease (PD) carrying GBA1 variants often develop advanced motor complications that prompt evaluation for deep brain stimulation (DBS). However, concerns about accelerated cognitive decline after DBS in GBA1 carriers complicate clinical decision making.
Evridiki Asimakidou, Micol Avenali, Jan O. Aasly, Mitra Afshari, Roy N. Alcalay, Sharlet Anderson, Carlo Alberto Artusi, Bryan Bernard, Marco Bozzali, Susan Bressman, Giovanna Calandra‐Buonaura, Francesco Cavallieri, Roberto Cilia, Jean‐Christoph Corvol, Antoniangela Cocco, Rob M.A. de Bie, Debra Ehrlich, Roberto Eleopra, Thomas Foltynie, Alessio Di Fonzo, Giulia Giannini, Christopher Goetz, Deborah Hall, Joohi Jimenez‐Shahed, Leonardo Lopiano, Vanessa Lythe, Maria Chiara Malaguti, Francesca Mameli, Graziella Mangone, Karen Marder, M. Maral Mouradian, Augusto Rini, Luisa Sambati, Rachel Saunders‐Pullman, Vicki Lynn Shanker, Francesca Spagnolo, Marie‐Laure Welter, Roberta Zangaglia, Gian Pal, Enza Maria Valente, PARKNET Study Group, Giada Cuconato, Ilaria Palmieri, Alberto Imarisio, Pierfrancesco Mitrotti, Francesca Valentino, Claudio Pacchetti, Gabriele Imbalzano, Claudia Ledda, Silvia Gallo, Pietro Cortelli, Luca Baldelli, Ilaria Cani, Raffaella Minardi, Valerio Carelli, Franco Valzania, Edoardo Monfrini, Filippo Cogiamanian, Chiara Longo, Fabiana Colucci, Luigi M. Romito, Marco Liccari   +61 more
wiley   +1 more source

Potent neutralization by antibodies targeting the MPXV A28 protein. [PDF]

Nat Commun
Yefet R, Battini L, Hubert M, Rakayev K, Guivel-Benhassine F, Rattner N, Porrot F, Abramovitz L, Ostashinsky G, Ben-Shalom N, Postal J, Polonsky K, Ralph-Altman M, Sweed S, Korner T, Friedel N, Hagin D, Sprecher E, Fishelson Z, Kobiler O, Adler-Abramovich L, Schwartz O, Guardado-Calvo P, Freund NT.   +23 more
europepmc   +1 more source

Determinants of Cueing Responsiveness in Parkinson's Disease: Insights from the UNITE‐PD Study

Movement Disorders, EarlyView.
Abstract Background Cueing strategies are widely used to improve gait in Parkinson's disease (PD), but interindividual variability in cueing responsiveness remains poorly understood. Objectives The objective of the study was to identify determinants of internal and external cueing efficacy in persons with PD.
Cindel Albers, Laura Avanzino, Elsa de Lange, Alessandro Botta, Zoya Katzir, Matan Bouter, Veronica Romano, Moran Gilat, Bastiaan R. Bloem, Joris van der Cruijsen, Inbal Maidan, Alice Nieuwboer, Elisa Pelosin, Anouk Tosserams, Vivian Weerdesteyn, Anat Mirelman, Jorik Nonnekes   +16 more
wiley   +1 more source

Evaluating the Therapeutic Efficacy of an Anti-BAFF Receptor Antibody Using a Rheumatoid Arthritis Mouse Model. [PDF]

Antibodies (Basel)
Aharon A, Birnboim-Perach R, Grotto O, Amir A, Diadko D, Beltran N, Nahary L, Benhar I.   +7 more
europepmc   +1 more source